In 2019, Bayer Hispania ranked as the manufacturer of basic pharmaceutical products with the highest sales value in Spain, with a total amount of 570 million euros. Instituto Grifols, a Spanish multinational specialized in plasma-derived medicines, ranked second on the list, with its sales valued at 437.9 million euros. The main enterprises in the manufacture of pharmaceutical preparations are Lilly and Novartis Farmacéutica. These generated a sales revenue of 1.7 and 1.2 billion euros, respectively.
In 2020, over 70 percent of the total sales in Spanish pharmacies came from prescription drugs. The OTC market accounted for almost 12 percent of the sales, while personal care products had a market share of eight percent. Antidiabetics was the category of prescription drugs with the highest revenue, amounting to 1.8 billion euros in 2020. In the case of over-the-counter pharmaceuticals, sales of eye care products amounted to more than 200 million euros.
The hospital pharmacy market in Spain has grown considerably in the last few years. In 2019, it reached 11.4 billion euros, almost 2.3 billion more than in 2016. The most important therapeutic areas in the hospital sector are oncology and auto-immune biologics, which together comprise 45 percent of the market. The oncological market had a value of approximately 3.6 million euros in, 2019, 21 percent more in comparison with the previous year.
…. more: Statista.com (Quelle/Source)